| abstract |
The present invention relates to compounds of the formula I, wherein A, D, E, G, R, R, R, Ry R have the meanings indicated in the claims, which are valuable active pharmaceutical compounds. They are cathepsin A protease inhibitors, and are useful, for example, for the treatment of diseases such as atherosclerosis, heart failure, kidney diseases, liver diseases or inflammatory diseases. The invention further relates to processes for preparing the compounds of formula I, their use and pharmaceutical compositions comprising them. |